HDAC5 and breast carcinoma: Not only that, the researchers found that LC3-II increased over time when HDAC5 was depleted in breast cancer cells, and this effect was enhanced with the use of lysosomal inhibitors, suggesting that HDAC5 downregulation increased autophagic flux (89).